Implementing Antiinflammatory Reliever Strategies in Asthma: The Evolving Paradigm of Asthma Management
- PMID: 38336438
- DOI: 10.1016/j.chest.2023.09.004
Implementing Antiinflammatory Reliever Strategies in Asthma: The Evolving Paradigm of Asthma Management
Erratum in
-
Corrigendum to: Chest. 2024;165(2):250-252.Chest. 2024 Jul;166(1):240. doi: 10.1016/j.chest.2024.05.002. Chest. 2024. PMID: 38986639 No abstract available.
Keywords: antiinflammatory; asthma management guidelines; barriers to implementation; reliever therapy.
Conflict of interest statement
Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: S. E. Z. has received consulting feeds from AstraZeneca. G. C. has received speaker and consultancy fees from Amgen, AstraZeneca, Boehringer Ingelheim, Genentech, GlaxoSmithKline, Novartis, Regeneron Pharmaceuticals, Sanofi Genzyme, and Teva Pharmaceuticals. None declared (M. N. E.). Role of sponsors: The sponsor had no role in the design of the study, the collection and analysis of the data, or the preparation of the manuscript.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
